Andrea Muscat Selected Research

romidepsin (FK228)

1/2009

Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Muscat Research Topics

Disease

5	Neoplasms (Cancer) 01/2018 - 08/2006
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2016 - 01/2009
1	Fatigue 01/2019
1	Febrile Neutropenia 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neutropenia 01/2019
1	Pneumothorax 01/2019
1	Pain (Aches) 01/2018
1	Neuroblastoma 08/2006

Drug/Important Bio-Agent (IBA)

3	PanobinostatIBA 01/2018 - 08/2012
2	Histone Deacetylase InhibitorsIBA 01/2016 - 01/2009
2	Histones (Histone)IBA 08/2012 - 01/2009
1	Albumin-Bound Paclitaxel FDA Link 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Epirubicin (Ellence)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	alizarinIBA 01/2016
1	ChromatinIBA 01/2009
1	romidepsin (FK228)FDA Link 01/2009
1	Biological ProductsIBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Caspase 8 (Caspase-8)IBA 08/2006
1	STAT1 Transcription FactorIBA 08/2006
1	Transcription Factors (Transcription Factor)IBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 08/2006

Therapy/Procedure

1	Neoadjuvant Therapy 01/2019
1	Therapeutics 01/2009